Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Adnan Anjum, Kanwal Shabbir, Fakhar Ud Din, Shumaila Shafique, Syed Saoud Zaidi, Ali H Almari, Taha Alqahtani, Aleena Maryiam, Muhammad Moneeb Khan, Adel Al Fatease, Sidra Bashir & Gul Majid Khan. (2023) Co-delivery of amphotericin B and pentamidine loaded niosomal gel for the treatment of Cutaneous leishmaniasis. Drug Delivery 30:1.
Read now
Read now
Kevin Matha, Brice Calvignac, Jean-Pierre Gangneux & Jean-Pierre Benoit. (2021) The advantages of nanomedicine in the treatment of visceral leishmaniasis: between sound arguments and wishful thinking. Expert Opinion on Drug Delivery 18:4, pages 471-487.
Read now
Read now
Indu Singh, Rajan Swami, Wahid Khan & Ramakrishna Sistla. (2014) Lymphatic system: a prospective area for advanced targeting of particulate drug carriers. Expert Opinion on Drug Delivery 11:2, pages 211-229.
Read now
Read now
Mohammad Ali, Mohammad Afzal, Shailja Misra Bhattacharya, Farhan Jalees Ahmad & Amit Kumar Dinda. (2013) Nanopharmaceuticals to target antifilarials: a comprehensive review. Expert Opinion on Drug Delivery 10:5, pages 665-678.
Read now
Read now
Alejandro Sosnik, Katia P Seremeta, Julieta C Imperiale & Diego A Chiappetta. (2012) Novel formulation and drug delivery strategies for the treatment of pediatric poverty-related diseases. Expert Opinion on Drug Delivery 9:3, pages 303-323.
Read now
Read now
Wahid Khan & Neeraj Kumar. (2011) Drug targeting to macrophages using paromomycin-loaded albumin microspheres for treatment of visceral leishmaniasis: an in vitro evaluation. Journal of Drug Targeting 19:4, pages 239-250.
Read now
Read now
Keitaro Sou, Beth Goins, Babatunde O Oyajobi, Bruno L Travi & William T Phillips. (2011) Bone marrow-targeted liposomal carriers. Expert Opinion on Drug Delivery 8:3, pages 317-328.
Read now
Read now
Swati Gupta, Ajay Pal & Suresh P Vyas. (2010) Drug delivery strategies for therapy of visceral leishmaniasis. Expert Opinion on Drug Delivery 7:3, pages 371-402.
Read now
Read now
Articles from other publishers (46)
Susana P. Mejía, Richard da Costa Marques, Katharina Landfester, Jahir Orozco & Volker Mailänder. (2023) Effect of Protein Corona on the Specificity and Efficacy of Nanobioconjugates to Treat Intracellular Infections. Macromolecular Bioscience.
Crossref
Crossref
Maria Jose Morilla, Kajal Ghosal & Eder Lilia Romero. (2023) More Than Pigments: The Potential of Astaxanthin and Bacterioruberin-Based Nanomedicines. Pharmaceutics 15:7, pages 1828.
Crossref
Crossref
Lucía Román-Álamo, Mohamad Allaw, Yunuen Avalos-Padilla, Maria Letizia Manca, Maria Manconi, Federica Fulgheri, Jorge Fernández-Lajo, Luis Rivas, José Antonio Vázquez, José Esteban Peris, Xavier Roca-Geronès, Srisupaph Poonlaphdecha, Maria Magdalena Alcover, Roser Fisa, Cristina Riera & Xavier Fernàndez-Busquets. (2023) In Vitro Evaluation of Aerosol Therapy with Pentamidine-Loaded Liposomes Coated with Chondroitin Sulfate or Heparin for the Treatment of Leishmaniasis. Pharmaceutics 15:4, pages 1163.
Crossref
Crossref
Muhammad Moneeb Khan, Syed Saoud Zaidi, Fahad Jibran Siyal, Saif Ullah Khan, Ghazala Ishrat, Sibgha Batool, Omer Mustapha, Salman Khan & Fakhar ud Din. (2023) Statistical optimization of co-loaded rifampicin and pentamidine polymeric nanoparticles for the treatment of cutaneous leishmaniasis. Journal of Drug Delivery Science and Technology 79, pages 104005.
Crossref
Crossref
Hamdi Nsairat, Dima Khater, Usama Sayed, Fadwa Odeh, Abeer Al Bawab & Walhan Alshaer. (2022) Liposomes: structure, composition, types, and clinical applications. Heliyon 8:5, pages e09394.
Crossref
Crossref
María Adelaida Gómez, Adriana Navas, Miguel Dario Prieto, Lina Giraldo-Parra, Alexandra Cossio, Neal Alexander & Nancy Gore Saravia. (2021)
Immuno-pharmacokinetics of Meglumine Antimoniate in Patients With Cutaneous Leishmaniasis Caused by
Leishmania
(
Viannia
)
. Clinical Infectious Diseases 72:10, pages e484-e492.
Crossref
Crossref
Katrien Van Bocxlaer & Simon L. Croft. (2021) Pharmacokinetics and pharmacodynamics in the treatment of cutaneous leishmaniasis – challenges and opportunities. RSC Medicinal Chemistry 12:4, pages 472-482.
Crossref
Crossref
Arturo Sánchez, Susana P. Mejía & Jahir Orozco. (2020) Recent Advances in Polymeric Nanoparticle-Encapsulated Drugs against Intracellular Infections. Molecules 25:16, pages 3760.
Crossref
Crossref
Juliana Kovalczuk de Oliveira, Tânia Ueda-Nakamura, Arlene Gonçalves Corrêa, Raquel Petrilli, Renata Fonseca Vianna Lopez, Celso Vataru Nakamura & Rachel Auzely-Velty. (2020) Liposome-based nanocarrier loaded with a new quinoxaline derivative for the treatment of cutaneous leishmaniasis. Materials Science and Engineering: C 110, pages 110720.
Crossref
Crossref
Laura Machín, Beatriz Tamargo, Abel Piñón, Regla C. Atíes, Ramón Scull, William N. Setzer & Lianet Monzote. (2019) Bixa orellana L. (Bixaceae) and Dysphania ambrosioides (L.) Mosyakin & Clemants (Amaranthaceae) Essential Oils Formulated in Nanocochleates against Leishmania amazonensis. Molecules 24:23, pages 4222.
Crossref
Crossref
Jully Oyama, Daniele Stéfanie Sara Lopes Lera-Nonose, Áquila Carolina Fernandes Herculano Ramos-Milaré, Fabiana Borges Padilha Ferreira, Camila Fabiano de Freitas, Wilker Caetano, Noboru Hioka, Thaís Gomes Verzignassi Silveira & Maria Valdrinez Campana Lonardoni. (2019) Potential of Pluronics® P-123 and F-127 as nanocarriers of anti-Leishmania chemotherapy. Acta Tropica 192, pages 11-21.
Crossref
Crossref
Mehdi Farhadi, Ali Haniloo, Kobra Rostamizadeh & Soghrat Faghihzadeh. (2018) Efficiency of flubendazole-loaded mPEG-PCL nanoparticles: A promising formulation against the protoscoleces and cysts of Echinococcus granulosus. Acta Tropica 187, pages 190-200.
Crossref
Crossref
Gul Shahnaz, Hafiz Shoaib Sarwar & Masoom Yasinzai. 2018. Leishmaniases as Re-emerging Diseases. Leishmaniases as Re-emerging Diseases.
Gert-Jan Wijnant, Katrien Van Bocxlaer, Vanessa Yardley, Andy Harris, Mo Alavijeh, Rita Silva-Pedrosa, Sandra Antunes, Isabel Mauricio, Sudaxshina Murdan & Simon L. Croft. (2018) Comparative efficacy, toxicity and biodistribution of the liposomal amphotericin B formulations Fungisome® and AmBisome® in murine cutaneous leishmaniasis. International Journal for Parasitology: Drugs and Drug Resistance 8:2, pages 223-228.
Crossref
Crossref
Gerald Geroldinger, Matthias Tonner, Werner Fudickar, Sritama De Sarkar, Aishwarya Dighal, Lianet Monzote, Katrin Staniek, Torsten Linker, Mitali Chatterjee & Lars Gille. (2018) Activation of Anthracene Endoperoxides in Leishmania and Impairment of Mitochondrial Functions. Molecules 23:7, pages 1680.
Crossref
Crossref
Mayara Cristina Pinto da Silva, Jefferson Mesquita Brito, Amalia dos Santos Ferreira, Andre Alvares Marques Vale, Ana Paula Azevedo dos Santos, Lucilene Amorim Silva, Paulo Vitor Soeiro Pereira, Flavia Raquel Fernandes Nascimento, Roberto Nicolete & Rosane Nassar Meireles Guerra. (2018)
Antileishmanial and Immunomodulatory Effect of Babassu-Loaded PLGA Microparticles: A Useful Drug Target to
Leishmania amazonensis
Infection
. Evidence-Based Complementary and Alternative Medicine 2018, pages 1-14.
Crossref
Crossref
J. Nieto, J. Alvar, C. Rodríguez, M.I. San Andrés, M.D. San Andrés & F. González. (2018) Comparison of conventional and lipid emulsion formulations of amphotericin B: Pharmacokinetics and toxicokinetics in dogs. Research in Veterinary Science 117, pages 125-132.
Crossref
Crossref
Gert-Jan Wijnant, Katrien Van Bocxlaer, Vanessa Yardley, Andy Harris, Sudaxshina Murdan & Simon L. Croft. (2018) Relation between Skin Pharmacokinetics and Efficacy in AmBisome Treatment of Murine Cutaneous Leishmaniasis. Antimicrobial Agents and Chemotherapy 62:3.
Crossref
Crossref
Maryam Akbari, Ahmad Oryan & Gholamreza Hatam. (2017) Application of nanotechnology in treatment of leishmaniasis: A Review. Acta Tropica 172, pages 86-90.
Crossref
Crossref
Hafiz Shoaib Sarwar, Sohail Akhtar, Muhammad Farhan Sohail, Zaeema Naveed, Muhammad Rafay, Akhtar Nadhman, Masoom Yasinzai & Gul Shahnaz. (2017)
Redox biology of
Leishmania
and macrophage targeted nanoparticles for therapy
. Nanomedicine 12:14, pages 1713-1725.
Crossref
Crossref
José Jardes da Gama Bitencourt, Wallance Moreira Pazin, Amando Siuiti Ito, Marina Berardi Barioni, Carolline de Paula Pinto, Maria Aparecida dos Santos, Thales Henrique Santos Guimarães, Márcia Regina Machado dos Santos & Claudete Justina Valduga. (2016) Miltefosine-loaded lipid nanoparticles: Improving miltefosine stability and reducing its hemolytic potential toward erythtocytes and its cytotoxic effect on macrophages. Biophysical Chemistry 217, pages 20-31.
Crossref
Crossref
Leticia Higa, Ana Perez, Priscila Schilrreff, Maria Morilla & Eder Romero. 2016. Nanotechnology and Drug Delivery, Volume Two. Nanotechnology and Drug Delivery, Volume Two
324
369
.
Víctor Gutiérrez, Amedea B. Seabra, Rosa M. Reguera, Jayant Khandare & Marcelo Calderón. (2016) New approaches from nanomedicine for treating leishmaniasis. Chemical Society Reviews 45:1, pages 152-168.
Crossref
Crossref
Muzamil Yaqub Want, Mohammad Islamuddin, Garima Chouhan, Anjan Kumar Dasgupta, Asoke Prasun Chattopadhyay & Farhat Afrin. (2014) A new approach for the delivery of artemisinin: Formulation, characterization, and ex-vivo antileishmanial studies. Journal of Colloid and Interface Science 432, pages 258-269.
Crossref
Crossref
CD Shaw & KC Carter. (2014)
Drug delivery: lessons to be learnt from
Leishmania
studies
. Nanomedicine 9:10, pages 1531-1544.
Crossref
Crossref
Marina Temi Shio, Marilene Paquet, Caroline Martel, Tom Bosschaerts, Stef Stienstra, Martin Olivier & Anny Fortin. (2014) Drug Delivery by Tattooing to Treat Cutaneous Leishmaniasis. Scientific Reports 4:1.
Crossref
Crossref
Mohammad Ali, Mohammad Afzal, Meenakshi Verma, Shailja Misra Bhattacharya, F. J. Ahmad, Mohammad Samim, M. Z. Abidin & A. K. Dinda. (2013) Therapeutic efficacy of poly (lactic-co-glycolic acid) nanoparticles encapsulated ivermectin (nano-ivermectin) against brugian filariasis in experimental rodent model. Parasitology Research 113:2, pages 681-691.
Crossref
Crossref
Alba Pujol, Patricia Urb��n, Cristina Riera, Roser Fisa, Israel Molina, Fernando Salvador, Joan Estelrich & Xavier Fern��ndez-Busquets. (2014) Application of Quantum Dots to the Study of Liposome Targeting in Leishmaniasis and Malaria. International Journal of Theoretical and Applied Nanotechnology.
Crossref
Crossref
Karolina Alicja Les, Abeer H. A. Mohamed-Ahmed, Sibu Balan, Ji-won Choi, Denis Martin, Vanessa Yardley, Keith Powell, Antony Godwin & Steve Brocchini. (2014) Poly(methacrylic acid) complexation of amphotericin B to treat neglected diseases. Polym. Chem. 5:3, pages 1037-1048.
Crossref
Crossref
Masoom YasinzaiMomin Khan, Akhtar Nadhman & Gul Shahnaz. (2013) Drug resistance in leishmaniasis: current drug-delivery systems and future perspectives. Future Medicinal Chemistry 5:15, pages 1877-1888.
Crossref
Crossref
Ricardo Fontoura de Carvalho, Ieler Ferreira Ribeiro, Ana Luisa Miranda-Vilela, José de Souza Filho, Olímpia Paschoal Martins, Débora de Oliveira Cintra e Silva, Antônio Cláudio Tedesco, Zulmira Guerrero Marques Lacava, Sônia Nair Báo & Raimunda Nonata Ribeiro Sampaio. (2013) Leishmanicidal activity of amphotericin B encapsulated in PLGA–DMSA nanoparticles to treat cutaneous leishmaniasis in C57BL/6 mice. Experimental Parasitology 135:2, pages 217-222.
Crossref
Crossref
Wahid Khan, Rajendra Kumar, Sukhvinder Singh, Sunil Kumar Arora & Neeraj Kumar. (2012) Paromomycin‐loaded albumin microspheres: Efficacy and stability studies. Drug Testing and Analysis 5:6, pages 468-473.
Crossref
Crossref
María Jesús Corral‐Caridad & José María Alunda. 2013. Trypanosomatid Diseases. Trypanosomatid Diseases
17
35
.
Abeer H. A. Mohamed-AhmedKarolina A. LesKarin SeifertSimon L. CroftStephen Brocchini. (2013) Noncovalent Complexation of Amphotericin-B with Poly(α-glutamic acid). Molecular Pharmaceutics 10:3, pages 940-950.
Crossref
Crossref
Abeer H. A. Mohamed-Ahmed, Karolina A. Les, Simon L. Croft & Stephen Brocchini. (2013) Preparation and characterisation of amphotericin B-copolymer complex for the treatment of leishmaniasis. Polym. Chem. 4:3, pages 584-591.
Crossref
Crossref
Abeer H. A. Mohamed-Ahmed, Claire Ginn, Simon L. Croft & Stephen Brocchini. 2013. Fundamentals of Pharmaceutical Nanoscience. Fundamentals of Pharmaceutical Nanoscience
429
464
.
Sofia A Costa LimaMariana Resende, Ricardo Silvestre, Joana Tavares, Ali Ouaissi, Paul Kong Thoo Lin & Anabela Cordeiro-da-Silva. (2012)
Characterization and evaluation of BNIPDaoct-loaded PLGA nanoparticles for visceral leishmaniasis:
in vitro
and
in vivo
studies
. Nanomedicine 7:12, pages 1839-1849.
Crossref
Crossref
Abeer H.A. Mohamed-Ahmed, Stephen Brocchini & Simon L. Croft. (2012) Recent advances in development of amphotericin B formulations for the treatment of visceral leishmaniasis. Current Opinion in Infectious Diseases 25:6, pages 695-702.
Crossref
Crossref
S. Kansal, R. Tandon, P. Dwivedi, P. Misra, P. R. P. Verma, A. Dube & P. R. Mishra. (2012) Development of nanocapsules bearing doxorubicin for macrophage targeting through the phosphatidylserine ligand: a system for intervention in visceral leishmaniasis. Journal of Antimicrobial Chemotherapy 67:11, pages 2650-2660.
Crossref
Crossref
Madhusudhan R. Papasani, Guankui Wang & Rodney A. Hill. (2012) Gold nanoparticles: the importance of physiological principles to devise strategies for targeted drug delivery. Nanomedicine: Nanotechnology, Biology and Medicine 8:6, pages 804-814.
Crossref
Crossref
Sofia Costa Lima, Vasco Rodrigues, Jorge Garrido, Fernanda Borges, Paul Kong Thoo Lin & Anabela Cordeiro da Silva. (2012) In vitro evaluation of bisnaphthalimidopropyl derivatives loaded into pegylated nanoparticles against Leishmania infantum protozoa. International Journal of Antimicrobial Agents 39:5, pages 424-430.
Crossref
Crossref
Fernando Leal-Calderon & Maud Cansell. (2012) The design of emulsions and their fate in the body following enteral and parenteral routes. Soft Matter 8:40, pages 10213.
Crossref
Crossref
Marzieh Aliaghaie, Hamid Mirzadeh, Erfan Dashtimoghadam & Shahrouz Taranejoo. (2012) Investigation of gelation mechanism of an injectable hydrogel based on chitosan by rheological measurements for a drug delivery application. Soft Matter 8:27, pages 7128.
Crossref
Crossref
Luiz C. Salay, Thatyane M. Nobre, Marcelle C. Colhone, Maria E. D. Zaniquelli, Pietro Ciancaglini, Rodrigo G. Stabeli, José Roberto S. A. Leite & Valtencir Zucolotto. (2011)
Dermaseptin 01 as antimicrobial peptide with rich biotechnological potential: study of peptide interaction with membranes containing
Leishmania amazonensis
lipid-rich extract and membrane models
. Journal of Peptide Science 17:10, pages 700-707.
Crossref
Crossref
Maria Jose Morilla & Eder Lilia Romero. 2011. Intracellular Delivery. Intracellular Delivery
745
811
.
Michael Look, Arunima Bandyopadhyay, Jeremy S. Blum & Tarek M. Fahmy. (2010) Application of nanotechnologies for improved immune response against infectious diseases in the developing world. Advanced Drug Delivery Reviews 62:4-5, pages 378-393.
Crossref
Crossref